Approval for Wipes System from VAH in Germany

RNS Number : 8688H

Tristel PLC

06 June 2011

 



Tristel plc

("Tristel" or "the Company")

AIM: TSTL

Approval for Wipes System from VAH in Germany

Tristel plc, the manufacturer of infection control, contamination control and hygiene products, announces that it has received confirmation from the German Association for Applied Hygiene (Verbund fur Angewandte Hygiene or VAH), that its Wipes System has been included on the VAH list of approved disinfectants.

Tristel's patented Wipes System is widely used worldwide for the decontamination of the small and delicate medical instruments used in hospital departments such as ear, nose and throat (ENT), cardiology and ultrasound.  The Wipes System was recently recognised by the ENT Societies in the United Kingdom and Italy as a preferred disinfection technique, and has also recently been approved by Australia's Therapeutic Goods Association.

Inclusion in the VAH list will enable Tristel to sell its Wipes System to public hospitals in Germany.  Hitherto, the Wipes System has only been available to private hospitals and clinics.  In the 8 month period that Tristel's German branch has been fully operational, the Wipes System has been adopted by 73 users in Germany.  The VAH certification significantly expands the Wipes System's sales potential in Europe's largest hospital market.  Germany has 2,100 hospitals and there are approximately 4,000 ENT consultants practising in the country.  This compares to approximately 600 public and private hospitals combined in the United Kingdom where the Wipes System is used in over 70% of ENT clinics.  Wipes System sales in the United Kingdom in the financial year ended 30 June 2010 were £1,449,000.

Paul Swinney, Chief Executive of Tristel, said: "The Wipes System is a unique product that is widely patented.  With its inclusion in Germany's VAH list we have made another great stride in establishing the Wipes System as the gold standard for the types of medical instrument used in specialist hospital departments such as ENT and cardiology.  Such specialist departments can be found in almost all hospitals worldwide, and are the areas specifically targeted as part of Tristel's international expansion plan."

Tristel plc
Paul Swinney, Chief Executive	Tel: [phone]
finnCap
Geoff Nash / Charlotte Stranner (Corporate Finance) Simon Starr (broking)	Tel: [phone]
Walbrook PR	Tel: [phone]
Paul McManus (Media Relations)	Mob: [phone]
	[e-mail]
Paul Cornelius (Investor Relations)	Mob: [phone]
	[e-mail]

 

END

 

 

REABUGDLSXGBGBX